The size of the worldwide clinical trials market is expected to experience brisk expansion over the course of the projected period. The global market for clinical trials generated revenue of USD 53.92 billion in 2022 and is projected to reach USD 85.01 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.93% over the period covered by the forecast.
Clinical Trials Market: Overview
Clinical trials are research investigations conducted on persons with the purpose of evaluating the efficacy of medicinal, behavioral, or surgical interventions. They are the most important platform for researchers to use in order to determine whether or not a new treatment is safe and effective in humans, such as a new diet, medical device, or pharmaceutical. Clinical research is also used to evaluate whether or not new medicines are more successful than existing therapies and/or have fewer adverse side effects.
In other clinical trials, researchers are looking for techniques to detect sickness at an earlier stage, even before the symptoms manifest themselves. In addition, it investigates potential treatments for a variety of medical conditions. A clinical study may also investigate ways in which individuals who are suffering from a life-threatening illness or a chronic health condition might make life simpler for themselves. Research conducted during clinical trials frequently investigates the participation of carers or support groups.
Before the Food and Drug Administration (FDA) of the United States gives its approval to begin a clinical trial, scientists carry out experimental experiments and testing on animals to determine whether or not a potential treatment is both safe and effective. The Food and Drug Administration (FDA) grants approval for the intervention to be tested on humans provided that the trials yield positive results.
Clinical Trials Market: Growth Factors
The expansion of the market is being driven by an increase in the incidence of chronic diseases as well as a surge in the desire for personalized treatment.
The global market for clinical trials is undergoing tremendous expansion as a result of several factors, including the expanding incidence of chronic and infectious diseases, the demand for personalized medication, and the development of new technologies. The increasing investments made by pharmaceutical and biotechnology businesses, as well as the favorable efforts taken by the government to assist clinical research and development, are further factors that are driving the market. Additionally, the increasing usage of virtual and decentralized clinical trials is supporting the growth of the market because these types of trials allow for quicker enrollment, cut the costs of trials, and offer greater patient experiences. In addition, the advent of contract research organizations, also known as CROs, is helping to expand the industry because these organizations provide drug developers with alternatives that are more efficient and affordable.
Clinical Trials Market: Segmentation
The market for worldwide clinical trials can be broken down into distinct submarkets according to phase, research design, indication, and geographic location.
The market was divided into Phase I, Phase II, Phase III, and Phase IV according to the phase of development. In 2022, the Phase III segment held the greatest market share, and over the course of the forecast period, it is anticipated to rise significantly at a significant compound annual growth rate (CAGR). The significance of this sector’s work in the field of medication development is the primary factor driving its expansion. The purpose of phase III clinical trials is to evaluate new medicines in terms of their efficacy and safety in comparison to already available treatments. These evaluations provide essential data for regulatory approval and market access.
Clinical Trials Market: Regional Analysis
North America region to dominate the global market during the forecast period
Based on region, the North American region held the dominating clinical trials market share in 2022 and is further predicted to grow at an exponential CAGR during the forecast period. North America is a major player in the clinical trials market, with the United States accounting for the majority of the region’s market share. The growth of the market in North America is driven by several factors, including the increasing prevalence of chronic & infectious diseases, the demand for personalized medicine, and the presence of a well-established pharmaceutical industry.
Clinical Trials Market: Competitive Players
The major players in the global clinical trials market include:
IQVIA
PPD
Covance
Parexel International
Syneos Health
Charles River Laboratories
ICON plc
Medpace
PRA Health Sciences
WuXi AppTec
Chiltern International
Celerion
Envigo
Eurofins Scientific
Frontage Laboratories
Laboratory Corporation of America Holdings (LabCorp)
Novotech Pty Ltd.
Pharmaron
Pharmaceutical Product Development LLC (PPD)
QuintilesIMS (now IQVIA)
Among Others.
The report segment of the global clinical trials market is as follows:
By Phase
Phase I
Phase II
Phase III
Phase IV
By Study Design
Observational
Interventional
Expanded Access
By Indication
Gastrointestinal
Cardiovascular
Autoimmune/Inflammation
Pain management
CNS condition
Cancer
Mental disorders
Oncology
Diabetes
Obesity
Others
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Contact US
Zion Market Research
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL-FREE +1 (855) 465-4651
Email:[email protected]
Read Also: